US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist
  • 8.490
  • -0.120-1.39%
Close Feb 28 16:00 ET
  • 8.500
  • +0.010+0.12%
Post 18:52 ET
496.77MMarket Cap-3.05P/E (TTM)

About Cullinan Therapeutics Company

Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Company Profile

SymbolCGEM
Company NameCullinan Therapeutics
Listing DateJan 8, 2021
Issue Price21.00
Founded2016
CEOMr. Nadim Ahmed
MarketNASDAQ
Employees111
Fiscal Year Ends12-31
AddressOne Main Street,Suite 1350
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-410-4650

Company Executives

  • Name
  • Position
  • Salary
  • Nadim Ahmed
  • Director, President and Chief Executive Officer
  • 4.01M
  • Dr. Jennifer Michaelson, PhD
  • Chief Scientific Officer
  • --
  • Dr. Corinne Savill, PhD
  • Chief Business Officer
  • --
  • Dr. Jeffrey Alan Jones, M.D.
  • Chief Medical Officer
  • 2.42M
  • Jacquelyn L. Sumer
  • Chief Legal Officer, Chief Compliance Officer and Secretary
  • --
  • Mary Kay Fenton
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Anthony Rosenberg
  • Chairman of the Board
  • 284.84K
  • David D. Meek
  • Director
  • --
  • Mary T. Thistle
  • Director
  • --
  • Dr. David P. Ryan, M.D.
  • Independent Director
  • 43.75K
  • Stephen W. Webster
  • Independent Director
  • 232.24K
  • Dr. Anne-Marie Martin, PhD
  • Independent Director
  • 164.45K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l Show More